Search Result

Results for "

PRRs

" in MedChemExpress (MCE) Product Catalog:

By Targets:	AIM2 (1) Bacterial (1) Biochemical Assay Reagents (1) Cyclic GMP-AMP Synthase (1) Endogenous Metabolite (1) HIV (1) Pyroptosis (1) Renin (1) Small Interfering RNA (siRNA) (18) Toll-like Receptor (TLR) (8)
By Research Areas:	Cancer (1) Cardiovascular Disease (1) Infection (3) Inflammation/Immunology (14)
Oligonucleotides:	Rat Pre-designed siRNA Sets (3) Mouse Pre-designed siRNA Sets (2) Adjuvant (12) Human Pre-designed siRNA Sets (13) siRNAs (18)

Inhibitors & Agonists

Peptides

Natural
Products

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-147089

PRRSV/CD163-IN-1	Bacterial Endogenous Metabolite	Infection Inflammation/Immunology
PRRSV/CD163-IN-1 is a PRRSV/CD163 inhibitor. PRRSV/CD163-IN-1 can inhibit the interaction between the PRRSV glycoprotein (GP2a or GP4) and the CD163-SRCR5 domain. PRRSV/CD163-IN-1 can be used for the research of porcine reproductive and respiratory syndrome (PRRS) .

HY-P3496

Pep19-2.5	Pyroptosis	Inflammation/Immunology
Pep19-2.5 is an synthetic and antitoxin peptide, blocks the intracellular endotoxin signaling cascade. Pep19-2.5 inhibits signaling of lipopeptides (LP) and lipopolysaccharides (LPS) mediated by transmembrane and cytosolic pattern recognition receptors (PRRs). The signaling cascades lead to inflammation and cell pyroptosis .

HY-P10933

PRO20	Renin	Cardiovascular Disease
PRO20 is a specific and competitive (pro)renin receptor (PRR) antagonist. PRO20 inhibits Prorenin-induced calcium influx with an IC₅₀ value of 81 nmol/L. PRO20 exerts antihypertensive activity by blocking the binding of prorenin to the PRR, inhibiting the activation of the renin-angiotensin system (RAS), and reducing the production of angiotensin II (Ang II). PRO20 is promising for research of antihypertensive agents .

HY-RS11223

PRR12 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR12 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR12 Human Pre-designed siRNA Set A PRR12 Human Pre-designed siRNA Set A

HY-RS11232

PRR5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR5 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR5 Human Pre-designed siRNA Set A PRR5 Human Pre-designed siRNA Set A

HY-RS11222

PRR11 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR11 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR11 Human Pre-designed siRNA Set A PRR11 Human Pre-designed siRNA Set A

HY-RS26838

Prr3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Prr3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prr3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prr3 Rat Pre-designed siRNA Set A Prr3 Rat Pre-designed siRNA Set A

HY-RS11226

PRR16 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR16 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR16 Human Pre-designed siRNA Set A PRR16 Human Pre-designed siRNA Set A

HY-RS24216

Prr4 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Prr4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prr4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prr4 Rat Pre-designed siRNA Set A Prr4 Rat Pre-designed siRNA Set A

HY-RS11234

PRR9 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR9 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR9 Human Pre-designed siRNA Set A PRR9 Human Pre-designed siRNA Set A

HY-RS11233

PRR7 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR7 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR7 Human Pre-designed siRNA Set A PRR7 Human Pre-designed siRNA Set A

HY-RS11225

PRR15 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR15 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR15 Human Pre-designed siRNA Set A PRR15 Human Pre-designed siRNA Set A

HY-RS20330

Prr3 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Prr3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prr3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prr3 Mouse Pre-designed siRNA Set A Prr3 Mouse Pre-designed siRNA Set A

HY-RS11230

PRR35 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR35 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR35 Human Pre-designed siRNA Set A PRR35 Human Pre-designed siRNA Set A

HY-RS22288

Prr7 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Prr7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prr7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prr7 Mouse Pre-designed siRNA Set A Prr7 Mouse Pre-designed siRNA Set A

HY-RS11224

PRR14 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR14 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR14 Human Pre-designed siRNA Set A PRR14 Human Pre-designed siRNA Set A

HY-RS11229

PRR3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR3 Human Pre-designed siRNA Set A PRR3 Human Pre-designed siRNA Set A

HY-RS11231

PRR4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR4 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR4 Human Pre-designed siRNA Set A PRR4 Human Pre-designed siRNA Set A

HY-RS11227

PRR20A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR20A Human Pre-designed siRNA Set A contains three designed siRNAs for PRR20A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR20A Human Pre-designed siRNA Set A PRR20A Human Pre-designed siRNA Set A

HY-RS11228

PRR21 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRR21 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRR21 Human Pre-designed siRNA Set A PRR21 Human Pre-designed siRNA Set A

HY-RS28811

Prr7 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Prr7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prr7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prr7 Rat Pre-designed siRNA Set A Prr7 Rat Pre-designed siRNA Set A

HY-138646

Poly(deoxyadenylic-thymidylic) acid sodium 1 Publications Verification Poly(dA:dT) sodium	Cyclic GMP-AMP Synthase AIM2	Infection Cancer
Polydeoxyadenylic-thymidylic acid (Poly(dA:dT)) sodium is a synthetic DNA polymer. Poly(dA:dT) sodium can be used to determine the activity of bound and free ribonucleic acid polymerase. Poly(dA:dT) sodium is recognized by multiple PRRs (cytosolic DNA sensors (CDS), including cGAS, AIM2, DAI, DDX41, IFI16, and LRRFIP1), and triggers the production of type I interferons. Poly(dA:dT) sodium can be used for the research of cancer and virus infection .

HY-159746

HS801	Biochemical Assay Reagents	Inflammation/Immunology
HS801 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159748

M402	Toll-like Receptor (TLR)	Inflammation/Immunology
M402 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159754

HS201	Toll-like Receptor (TLR)	Inflammation/Immunology
HS201 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159753

HS105	Toll-like Receptor (TLR)	Inflammation/Immunology
HS105 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159743

M101	Toll-like Receptor (TLR)	Inflammation/Immunology
M101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159751

HS101	Toll-like Receptor (TLR)	Inflammation/Immunology
HS101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159744

M103	Toll-like Receptor (TLR)	Inflammation/Immunology
M103 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159747

M401	Toll-like Receptor (TLR)	Inflammation/Immunology
M401 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-159750

M903	Toll-like Receptor (TLR)	Inflammation/Immunology
M903 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .

HY-152157

HIV-1 inhibitor-52	HIV	Infection
HIV-1 inhibitor-52 is a potent broad-spectrum HIV-1 activity inhibitor with EC₅₀s of 1.6 nM-6.4 nM for WT HIV-1, HIV-1 V370A, HIV-1 ΔV370, HIV-1 V362I/V370A, HIV-1 T332S/V362I/prR41G, HIV-1 A326T/V362I/V370A, HIV-1 R361K/V362I/L363M .

Cat. No.	Product Name	Target	Research Area